May 8–9, 2018

Stanford University, Stanford, California


VIEW THE 2018 PANEL DISCUSSIONS

THE LIGHT STORY


The LIGHT Forum: Leaders In Global Healthcare and Technology is a conference designed for leaders from a broad cross-section of executives and top policy makers in the health-care field to discuss the latest developments, challenges and opportunities shaping the industry. Working hand in hand with leading thinkers from Silicon Valley, the event provides attendees with an ideal forum for networking as well as rigorous analysis and foresight.

The global health-care industry is at a turning point. The rise of personalized medicine, fundamental change in how healthcare is paid for, an explosion of data, and the transformation of the industry into a “global game” are just some of the most powerful forces roiling the landscape. At the same time, dramatic advances in artificial intelligence mean that big data and so-called “deep learning” offer the potential of unprecedented insight and market power for those who figure out how to harness these tools.

The initiative has been conceived to help the world’s top healthcare executives seize the moment.

ROAM Light Stanford Linguistics

+

2018 EDITION SPEAKERS


Click on the speaker's photo to read his/her bio.

  • Governor Haley Barbour

    Founding Partner, BGR Group

    Peter Brabeck-Letmathe

    Chairman Emeritus, Nestlé S.A.

    Olivier Brandicourt, MD

    CEO, Sanofi

  • M. Kate Bundorf, PhD

    Associate Professor of Health Research and Policy at the Stanford University School of Medicine; Associate Professor, by Courtesy, at the Stanford Graduate School of Business

    Paul Cheesbrough

    Chief Technology Officer, 21st Century Fox

    John H. Cochrane, PhD

    Jack & Rose-Marie Anderson Senior Fellow, Hoover Institution

  • Ron Cohen, MD

    President & CEO, Acorda Therapeutics

    Governor Gray Davis

    Former Governor of California; Of Counsel at Loeb & Loeb, LLP

    Martin Dewhurst

    Senior Partner, Global Pharmaceutical and Medical Products Practice, McKinsey & Company

  • Bill George

    Senior Fellow, Harvard Business School; Former Chairman and Chief Executive Officer, Medtronic; Author of Discover Your True North

    Jeff George

    CEO of Performance Health

    John Glasspool

    Board Member, Dalcor

  • James Greenwood

    President and CEO of the Biotechnology Innovation Organization (BIO)

    George Halvorson

    CEO and Chair Institute for InterGroup Understanding; Former Chair and CEO of Kaiser Permanente

    Gigi Hirsch, MD

    Executive Director of the MIT Center for Biomedical Innovation

  • Omar Ishrak, PhD

    Chairman & CEO, Medtronic

    Joseph Jimenez

    Former CEO, Novartis

    Jeffrey B. Kindler

    CEO, Centrexion Corporation

  • Joe Lonsdale

    Partner, 8VC;
    Founder, Palantir and Addepar

    Andrew Maas, PhD

    Co-Founder & Co-Chief Scientist at Roam Analytics

    Paul Markovich

    President and CEO,
    Blue Shield of California

  • Governor Terry McAuliffe

    72nd Governor of Virginia

    Mark McClellan, MD

    Director, Margolis Center for Health Policy at Duke University

    William F. McKeon

    President and Chief Executive Officer, Texas Medical Center

  • Lloyd Minor, MD

    Dean, Stanford University School of Medicine

    Senator George Mitchell

    Partner & Chairman Emeritus,
    DLA Piper

    Brendan Mullen

    Executive Vice President, American College of Cardiology

  • Peter Orszag, PhD

    Vice Chairman of Investment Banking & Global Co-Head of Healthcare, Lazard Freres & Co. LLC

    DJ Patil, PhD

    Former U.S. Chief Data Scientist

    Pamela Peele, PhD

    Chief Analytics Officer UPMC Health Plan and UPMC Enterprises

  • Ambassador Tom Pickering

    Vice Chairman, Hills & Company

    Chris Potts, PhD

    Professor, Stanford University Department of Linguistics

    Ambassador Susan E. Rice

    Distinguished Visiting Research Fellow at the School of International Service, American University; Non-Resident Senior Fellow at the Belfer Center for Science and International Affairs at Harvard’s Kennedy School of Government

  • Peter M. Robinson

    Murdoch Research Fellow,
    Hoover Institution

    Amir Rubin

    President and CEO, One Medical

    John S. Rumsfeld, MD, PhD

    Chief Innovation Officer for the American College of Cardiology (ACC) and Professor of Medicine at the University of Colorado School of Medicine

  • Mehran Sahami, PhD

    Professor, Stanford Artificial Intelligence Laboratory

    Susan Schaeffer

    Editor, BioCentury

    Dr. Kori Schake, PhD

    Deputy Director-General of the International Institute for Strategic Studies

  • Sara Singer, PhD

    Professor of Medicine at the Stanford University School of Medicine and Professor by courtesy at the Stanford Graduate School of Business

    John Thornhill

    Innovation Editor, The Financial Times

    Kismet Toksu

    CEO, eBenefits

  • Alex Turkeltaub

    CEO and Co-Founder, Roam Analytics

Governor Haley Barbour
Founding Partner, BGR Group

Haley Barbour, Founding Partner of BGR Group, returned to BGR in January 2012 after serving two consecutive terms as Governor of Mississippi, including two years as the Chairman of the Republican Governors Association. At BGR, he heads advocacy coalitions, lobbies on behalf of his clients and remains a major force in Republican party politics and elections. Gov. Barbour began his political career in 1968, dropping out of college to work on Richard Nixon’s presidential campaign; in 1976, after supporting Ronald Reagan for the GOP nomination, he ran Gerald Ford’s fall campaign in the Southeast. In 1982, he ran for U.S. Senate in Mississippi but lost to incumbent John C. Stennis. Gov. Barbour later served as Political Director of the Reagan White House. In 1987, he cofounded the government affairs firm that later became BGR Group. From 1993 to 1997, Gov. Barbour served as Chairman of the Republican National Committee, managing the 1994 Republican surge that led to GOP control of both Houses of Congress for the first time in 40 years.

In 2003, he was elected Governor of Mississippi, assuming office in January 2004. During his tenure as governor, Barbour led his state to adopt what the Wall Street Journal called the most comprehensive tort reform in the country. His team generated numerous large economic projects in the energy, aerospace and automotive fields, including the selection by Toyota of Blue Spring, Miss., for the company’s newest U.S. auto assembly plant, which was the most sought-after economic development project in the United States that year. In Gov. Barbour’s eight years as governor, per capita income in the state increased by 34 percent.

After Hurricane Katrina hit the Gulf Coast in 2005, Gov. Barbour received national recognition from the bipartisan American Legislative Exchange Council for his swift response to the worst natural disaster in American history. In 2015 he published America’s Great Storm: Leading Through Hurricane Katrina, a memoir of the year after the storm from the Governor’s perspective and lessons in leadership from the mega-disaster. For his efforts to rebuild the Mississippi Gulf Coast, he received the Thomas Jefferson Freedom Award. Other awards during his tenure as Governor included being named Governor of the Year by Governing Magazine, receiving the Gulf Guardian Award by the U.S. Environmental Protection Agency in recognition of his work to rebuild Gulf Coast ecosystems, and receiving the Adam Smith Award from BIPAC to honor his pursuit of the principles of free enterprise.

A native of Yazoo City, Miss., Gov. Barbour attended the University of Mississippi, where he received his JD in 1973. Governor Barbour resides in Yazoo City with his wife Marsha. They have two sons and seven grandchildren.

Peter Brabeck-Letmathe
Chairman Emeritus, Nestlé S.A.
On April 6th, 2017, Peter Brabeck-Letmathe was appointed Chairman Emeritus of Nestlé S.A. Previously, he led the Nestlé Group from 1997 to 2008, first as CEO till 2005, and then as Chairman and CEO. In April 2008, he handed over the office of CEO and remained Chairman of the Board of Nestlé S.A. Born in 1944 in Austria, Peter Brabeck-Letmathe graduated from the University of World Trade in Vienna with a degree in Economics. After joining the Nestlé Group in 1968, he spent a significant part of his career in Latin America, before being transferred to Nestlé’s International Headquarter in Vevey as Senior Vice-President. Appointed Executive Vice-President as of 1992 and Member of the Executive Board, he was in charge of the Strategic Business Units, Marketing & Sales, as well as Corporate Communications. BOARD MANDATES Peter Brabeck-Letmathe serves as Vice-Chairman of the Foundation Board of the World Economic Forum. He is an Independent Director of Delta Topco (Formula 1) and serves as member of the Advisory Board of Amrop. He also served as a Board Member of Roche, Credit Suisse, L’Oréal and Exxon Mobil Corporation. In addition, he was Chairman of the 2030 Water Resources Group, a Public Private Partnership. AWARDS Peter Brabeck-Letmathe has received several awards, including the Austrian Cross of Honour for services to the Republic of Austria, "La Orden Mexicana del Águila Azteca", "La Orden Francisco de Miranda" conferred by the republic of Venezuela, and the Schumpeter Prize for outstanding contribution in disruptive Innovation. The University of Alberta (Canada) conferred an Honorary Degree of Doctor of Laws on him. Recently, Mr. Brabeck-Letmathe has been inducted into the American Advertising Federation’s “Hall of Fame”.
Olivier Brandicourt, MD
CEO, Sanofi
Olivier Brandicourt joined Sanofi in April 2015 as Chief Executive Officer. Prior to joining the Group, Brandicourt was Chief Executive Officer of Bayer Healthcare AG (2013-2015). From 2000 through to 2013, he held a series of leadership positions at Pfizer culminating as a member of the Executive Leadership Team and as President and General Manager of the Emerging Markets and Established Products business units. Brandicourt started his career in the pharmaceutical industry in 1987 as a Medical Director for the Region Africa at Warner-Lambert/Parke-Davis, where he held other senior positions in medical and marketing before being appointed General Manager of Canada. He also spent eight years with the Institute of Infectious and Tropical Diseases at the Pitié-Salpêtrière Hospital in Paris with a focus on malaria research in West and Central Africa and two years in the Republic of Congo as a doctor. Olivier Brandicourt studied medicine in Paris where he specialized in Infectious Diseases and Tropical Medicine (University of Paris V) and holds an Advanced Degree in Cellular and Immunological Pathophysiology from the Paris Descartes University. He also holds a Master’s Degree in Biology (University of Paris XII).
M. Kate Bundorf, PhD
Associate Professor of Health Research and Policy at the Stanford University School of Medicine; Associate Professor, by Courtesy, at the Stanford Graduate School of Business
M. Kate Bundorf is an Associate Professor of Health Research and Policy at the Stanford University School of Medicine, an Associate Professor, by Courtesy, at the Stanford Graduate School of Business, a Stanford Health Policy Fellow, and a Senior Fellow at the Stanford Institute for Economics and Policy Research. She is also a Research Associate at the National Bureau of Economic Research. She received her M.B.A. and M.P.H. degrees from The University of California at Berkeley and her Ph.D. from The Wharton School. She was a Fulbright Lecturer and Visiting Professor at Fudan University School of Public Health in Shanghai, China in 2009 and 2010. Her research, which focuses on health insurance and health care provider markets, has been published in leading economics and health policy journals and has received funding from the U.S. National Institutes of Health, the Agency for Health Care Research and Quality, the Robert Wood Johnson Foundation, and the Patient Centered Outcomes Research Institute. She received the 13th Annual Health Care Research Award from The National Institute for Health Care Management in 2007 and was a finalist for the award in 2013. She is an editorial board member of the Journal of Health Economics, the American Journal of Health Economics, Health Services Research and Medical Care Research and Review and an associate editor for the International Journal of Health Economics and Management. She is currently a member of the Panel of Health Advisors for the Congressional Budget Office and has served on the Technical Review Panel for the Medicare Trustees Reports.
Paul Cheesbrough
Chief Technology Officer, 21st Century Fox

Paul Cheesbrough is Chief Technology Officer for 21st Century Fox. In this role Mr. Cheesbrough oversees the company’s technology strategy and operations on a global basis. He joined 21st Century Fox in December 2016.

Prior to this, he served as Chief Technology Officer for News Corp, overseeing the enterprise technologies and digital products and platforms across the business as well as the technology investment portfolio. In this role he led significant change across the business, moving it to more cloud-based technologies and putting innovation and engineering at the heart of the organizations owned by the company.

Before joining News Corp, Mr. Cheesbrough served as Chief Information Officer at the Telegraph Media Group, where he pioneered the development of a wide range of new digital products. Prior to the Telegraph, he was the Controller of Digital Media for the BBC, having started his career in IBM within its media division as a software engineer.

John H. Cochrane, PhD
Jack & Rose-Marie Anderson Senior Fellow, Hoover Institution
John H. Cochrane is a senior fellow at the Hoover Institution. He is also a research associate of the National Bureau of Economic Research and an adjunct scholar of the CATO Institute. Before joining Hoover, Cochrane was a Professor of Finance at the University of Chicago’s Booth School of Business, and earlier at its Economics Department. Cochrane earned a bachelor’s degree in physics at MIT and his PhD in economics at the University of California at Berkeley. He was a junior staff economist on the Council of Economic Advisers (1982–83). Cochrane’s recent publications include the book Asset Pricing and articles on dynamics in stock and bond markets, the volatility of exchange rates, the term structure of interest rates, the returns to venture capital, liquidity premiums in stock prices, the relation between stock prices and business cycles, and option pricing when investors can’t perfectly hedge. His monetary economics publications include articles on the relationship between deficits and inflation, the effects of monetary policy, and the fiscal theory of the price level. He has also written articles on macroeconomics, health insurance, time-series econometrics, financial regulation, and other topics. He was a coauthor of The Squam Lake Report. His Asset Pricing PhD class is available online via Coursera. Cochrane frequently contributes editorial opinion essays to the Wall Street Journal, Bloomberg.com, and other publications. He maintains the Grumpy Economist blog.
Ron Cohen, MD
President & CEO, Acorda Therapeutics
Ron Cohen, M.D. is President, CEO and founder of Acorda Therapeutics, Inc., a public biotechnology company developing therapies for disorders of the nervous system, including multiple sclerosis, Parkinson’s disease and migraine. Dr. Cohen previously was a principal in the startup and an officer of Advanced Tissue Sciences, Inc., a biotechnology company engaged in the growth of human organ tissues for transplantation uses. He serves as a Director on the Board of Directors of VBL Therapeutics. He previously served as a Director on the Board of Dyax Corp. until its acquisition in 2016. He also previously served as Chair of the Board of the Biotechnology Innovation Organization (BIO), as Chair of the Emerging Companies Section of the BIO Board, and as Director and Chair of the New York Biotechnology Association (NYBA). Dr. Cohen is a member the Columbia-Presbyterian Health Sciences Advisory Council and was awarded Columbia University’s Alumni Medal for Distinguished Service. Acorda Therapeutics has been recognized as one of the Best Companies to Work for in New York State seven years in a row (2011-2017), among the Fortune 100 Best Medium-Size Workplaces the U.S. (2017), and among the Fortune 100 Best Workplaces for Women (2016-2017), Millennials (2017) and Baby Boomers (2017). Dr. Cohen is a recipient of the NY CEO Lifetime Achievement Award and the Ernst & Young Entrepreneur of the Year Award for the New York Metropolitan Region. He was named Neuroinvestment’s CEO of the Year and is an inductee of the National Spinal Cord Injury Association’s “Spinal Cord Injury Hall of Fame.” Dr. Cohen received the Burke Award from Burke Rehabilitation Hospital for his contributions to helping people with disabilities gain independence. He has been recognized by the New York Biotechnology Association as the NYBA “The Cures Start Here” Business Leader of the Year, by the Westchester County Association as its Leadership Award recipient, by Life Science Leader Magazine as True Life Science Leader of the year, by PR Week/MM&M as one of the Health Influencer 50, and by PharmaVOICE Magazine as one of the 100 Most Inspirational People in the Biopharmaceutical Industry. Dr. Cohen received his B.A. degree with honors in Psychology from Princeton University, and his M.D. from the Columbia College of Physicians & Surgeons. He completed a residency in Internal Medicine at the University of Virginia Medical Center, and is Board Certified in Internal Medicine.
Governor Gray Davis
Former Governor of California; Of Counsel at Loeb & Loeb, LLP

Joseph "Gray" Davis was overwhelmingly elected the 37th governor of California in 1998, winning 58 percent of the vote. As Governor, he made education a top priority, signing legislation to strengthen California's K-12 system by establishing the Academic Performance Index to increase accountability in schools, and expanding access to higher education with a record number of scholarships and college loans. These reforms improved student achievement scores for six consecutive years.

While presiding over California during an unprecedented economic expansion – where the State became the 5th largest global economy, Davis made record investments in infrastructure, created four Centers of Science and Innovation on UC campuses, and expanded state health insurance for an additional one million children. He also was the first Governor in the nation to authorize stem cell research.

As Governor he demonstrated bold environmental leadership by signing the first law in the nation to reduce global warming and greenhouse gases. He also created the first Greenhouse Gas Monitoring Registry, and was the first to establish the nation's most ambitious commitment to renewable energy by creating the statewide Renewables Portfolio Standard.

Despite a wave of Republican victories across the nation in 2002, Davis was re-elected to a second term.

Davis graduated from Stanford University (Cum Laude) and Columbia Law School, and was awarded the Bronze Star for his service during the Vietnam War. He served as lieutenant governor (1995-1998), state controller (1987-95), and state assemblyman (1982-86).

Davis is Of Counsel in the Los Angeles office of Loeb & Loeb, LLP where he provides strategic advice to clients on numerous matters. He is also a member of the bi-partisan Think Long Committee, a Senior Fellow at the UCLA School of Public Affairs, Co-Chair of the Southern California Leadership Council, and speaks before a number of civic and government organizations on important issues of the day. Governor Davis was also honored to be the Keynote Speaker at the Columbia Law School Graduation Ceremony in May of 2009.

Martin Dewhurst
Senior Partner, Global Pharmaceutical and Medical Products Practice, McKinsey & Company

Martin joined McKinsey in 1992. He leads our Global Pharmaceutical and Medical Products Practice (PMP) and is responsible for our overall client service agenda, our knowledge and research priorities, our offerings to clients and the development of our people. He also sits on the board of VeryDay – a globally leading design company – recently acquired by McKinsey.

He has spoken widely on the future of the industry - with over 20 company Boards /CEO exec meetings and at numerous conferences including AsiaPac MedTech Forum, BioCentruy Conference in Shanghai, EUCOMED and St Petersburg economic forum, among others.

Martin was previously head of our Organization Practice in EMEA spanning leadership development, human capital, transformational change, organization design and post-merger integration. He has written and spoken frequently on globalisation. He has published in the Harvard Business Review (2013) and led a panel on emerging markets at the Economist conference.

Martin joined McKinsey from INSEAD (Dean’s List) where he earned an MBA in general management. Beyond McKinsey, Martin serves as Trustee to Asia House (UK’s centre of expertise on Asia)

Prior to INSEAD, Martin spent 5 years in consulting and product management in new technologies. In 1985 he completed a BA Hons from Magdalen College, Oxford.

Bill George
Senior Fellow, Harvard Business School; Former Chairman and Chief Executive Officer, Medtronic; Author of Discover Your True North

Bill George is a senior fellow at Harvard Business School, where he has taught leadership since 2004. He is the author of: Discover Your True North and The Discover Your True North Fieldbook, Authentic Leadership, True North, Finding Your True North, 7 Lessons for Leading in Crisis and True North Groups.

Mr. George is the former chairman and chief executive officer of Medtronic. He joined Medtronic in 1989 as president and chief operating officer, was chief executive officer from 1991-2001, and board chair from 1996-2002. Earlier in his career, he was a senior executive with Honeywell and Litton Industries and served in the U.S. Department of Defense.

Mr. George currently serves as a director of Goldman Sachs. He has served recently on the boards of ExxonMobil, Novartis, Target Corporation, Minnesota’s Destination Medical Center Corporation and the World Economic Forum USA. Bill is currently a trustee of the Mayo Clinic, and has served as board chair for Allina Health System, Abbott-Northwestern Hospital, United Way of the Greater Twin Cities, and Advamed.

In April 2014 the Franklin Institute awarded him the Bower Award for Business Leadership. He was elected to the National Academy of Engineering in 2012. He has been named one of "Top 25 Business Leaders of the Past 25 Years" by PBS; "Executive of the Year-2001" by the Academy of Management; and "Director of the Year-2001-02" by the National Association of Corporate Directors. Mr. George is a CNBC Contributor and has made frequent appearances on television and radio.

He received his BSIE with high honors from Georgia Tech, his MBA with high distinction from Harvard University, where he was a Baker Scholar, and honorary PhDs from Georgia Tech, Mayo Medical School, University of St. Thomas, Augsburg College and Bryant University. During 2002-03 he was professor at IMD International and Ecole Polytechnique in Lausanne, Switzerland, and executive-in-residence at Yale School of Management.

He and his wife Penny reside in Minneapolis, Minnesota.

Jeff George
CEO of Performance Health

Jeff has served as CEO and a Board director at Performance Health since February 2018. Performance Health is a leader in consumer healthcare and is the largest global manufacturer and distributor of products to the physical therapy, sports medicine, and rehabilitation markets, and is owned by the private equity firm Madison Dearborn Partners. Its market-leading brands include Biofreeze®, TheraBand®, TheraPearl®, Cramer®, Sammons Preston®, and Rolyan®.

Jeff previously served on the Novartis Group Executive Committee from 2008 to 2016, first as Division Head and CEO of Sandoz (2008-2014), Novartis’s $10 billion generic pharmaceuticals and biosimilars subsidiary, and then as Division Head and CEO of Alcon (2014-2016), Novartis’s then $10 billion eye care subsidiary. In both of his divisional CEO roles at Novartis, Jeff was responsible for leading over 25,000 associates globally across more than 160 countries and had primary line leadership and management responsibility for all functions, regions, and franchises.

Prior to leading Sandoz, Jeff served on the Novartis Pharma Executive Committee as Head of Emerging Markets for the Middle East, Africa, Southeast Asia and CIS, after serving as Vice President and Head of Western & Eastern Europe for Novartis Vaccines. Before joining Novartis, Jeff was Senior Director of Strategic Planning and Business Development at Gap Inc., where he led growth, licensing, and European expansion efforts for one of its apparel divisions. Prior to this, he was an Engagement Manager at McKinsey & Company in San Francisco. Jeff has also worked in emerging markets private equity in South Africa and in Washington, D.C.

Jeff holds an MBA from Harvard Business School and a master’s degree from Johns Hopkins University’s School of Advanced International Studies (SAIS), where he studied international economics and emerging markets political economy. He received his B.A. in international relations, magna cum laude and Phi Beta Kappa, from Carleton College.

Jeff serves on the Board of Directors at Roam Analytics, a Stanford- and venture-backed Silicon Valley machine learning and artificial intelligence healthcare data analytics firm. He served on the Board of Directors for AdvaMed from 2014 to 2016 and is a member of the Young President’s Organization (YPO). He was twice named to Fortune’s “40 under 40” list of up-and-coming leaders. Jeff is married with two daughters and enjoys running, coaching soccer, live music, meditation, and international affairs.

John Glasspool
Board Member, Dalcor
As a seasoned pharmaceutical executive with over 25 years of experience in the industry, Royston John Glasspool has extensive experience in multiple line and staff functions in the US, UK, Europe, and global markets through his roles of increasing responsibility at Scotia Pharmaceuticals, Johnson & Johnson, Novartis, Baxter, and Baxalta. This experience has helped him architect innovative approaches to patient-centered drug development within the companies he has served, such as the P5 planning process and patient access approach. He has led franchises with over $6B in sales and has launched over 10 products. He is regularly invited to expert panels and also serves on the Board of Directors of the Biotechnology Industry Organization (BIO). John holds 2 patents and has degrees in politics and international relations from the University of Staffordshire, UK, and in business administration from Oxford Brookes University with a focus on international marketing. Before joining the pharmaceutical industry, John owned a restaurant and small hotel. John lives in Hingham, MA with his wife Susan, daughter Samantha, and cat Sushi.
James Greenwood
President and CEO of the Biotechnology Innovation Organization (BIO)
James C. Greenwood is President and CEO of the Biotechnology Innovation Organization (BIO) in Washington, D.C. BIO represents 1,000 biotechnology companies, academic institutions, state biotechnology centers, and related organizations across the United States and in more than 30 countries worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, and industrial & environmental biotechnology products. BIO also produces the annual BIO International Convention, the world's largest annual gathering of the biotechnology industry, as well as other major investor and business conferences across the world. Greenwood represented Pennsylvania's Eighth District in the U.S. House of Representatives from 1993 to 2005. Since 2005, his deep relationships on Capitol Hill and knowledge of politics and policy have substantially raised BIO’s profile and enhanced the organization’s advocacy work. During his time in Congress, he was a senior member of the Energy and Commerce Committee and widely viewed as a leader on health care and the environment. He crafted legislation to reform the Food and Drug Administration, and he led the fight in Congress to allow stem-cell research to be conducted by U.S. scientists to treat disease. From 2001 to 2004, Greenwood served as Chairman of the Energy and Commerce Committee Subcommittee on Oversight and Investigation with oversight authority over issues in the full Committee's jurisdiction. He led hard-hitting investigations into corporate governance at Enron, Global Crossing and WorldCom; terrorist threats to our nation's infrastructure; and waste and fraud in federal government agencies. Prior to his election to Congress, Greenwood served six years in the Pennsylvania General Assembly (1981-86) and six years in the Pennsylvania Senate (1987-1992). Greenwood graduated from Dickinson College in 1973 with a B.A. in Sociology. From 1977 until 1980, he worked as a caseworker with abused and neglected children at the Bucks County Children and Youth Social Service Agency. Mr. Greenwood is married with three children and resides in Upper Makefield, Pennsylvania.
George Halvorson
CEO and Chair Institute for InterGroup Understanding; Former Chair and CEO of Kaiser Permanente

George Halvorson is Chair and CEO of the Institute for InterGroup Understanding. He has served for more than 30 years as CEO of six different health care delivery and financing organizations in the U.S., and he helped start similar health care organizations in several other countries. Most recently Halvorson served as Kaiser Permanente Chairman and CEO from 2002 – 2014, before retiring as CEO in July 2013, and Chairman in January 2014.

Halvorson is currently Chair of the First 5 Commission for Children and Families for the State of California. In 2013 Governor Jerry Brown appointed Halvorson to a four-year term as Chair, and then re-appointed him to another four years in 2017. The Commission uses roughly $500 million each year — raised from tobacco taxes — to provide support and education to children in California from birth to 5 years old.

Halvorson is a member of the Right Start Commission for Children in the State of California, and an advisory council member for the Too Small To Fail Commission. He currently serves as a member of the CEO Advisory Council for the Ready Nation coalition.

The Institute for InterGroup Understanding works on issues of racism, prejudice, discrimination, misogyny, and InterGroup stress and conflict. Halvorson has written four books on those topics, which are all available as teaching materials from the Institute.

Electronic versions of the InterGroup books can be downloaded or read directly from the Institute for InterGroup Understanding website at no charge. (Hard copies of the books are available at Amazon.com.)

The books and the Institute website explain how our instinctive behaviors steer us into conflict in various intergroup settings, and outline and explain the steps we should take to create intergroup Peace.

Halvorson recently revised The Art of InterGroup Peace — his book on achieving intergroup peace around the world — into its Third Edition, which can be downloaded for free at the Institute for InterGroup Understanding website.

Three Key Years, one of Halvorson’s most recent titles, is paramount to early childhood education, and explains the importance of positive interactions between caring adults and infants in their first three years of life. Halvorson also designed threekeyyears.org, a website dedicated to educating new parents on the simple steps they should take in a child’s first three years to improve their lives forever.

His final health care book, Don’t Let Health Care Bankrupt America, explains how to use market forces and extensive care support tools to make health care significantly better and more affordable. The book describes actual tools and processes Halvorson used while running the largest private care system in America.

Gigi Hirsch, MD
Executive Director of the MIT Center for Biomedical Innovation
Dr. Hirsch is the Executive Director of the MIT Center for Biomedical Innovation (CBI), which focuses on improving global health by overcoming challenges to the development, diffusion and adoption of biomedical innovations. Her current efforts at CBI center on leading the New Drug Development Paradigms initiative (NEWDIGS), a “think and do tank” that is re-engineering pharmaceutical innovation to drive more value faster to patients, in ways that work for all stakeholders. Utilizing the broad strategic framework of “Adaptive Biomedical Innovation (ABI),” NEWDIGS’ flagship project focuses on aligning stakeholders around more adaptive, patient-centered approaches to the management of risk and uncertainty across the life span of new medicines. This project led to Dr. Hirsch’s invited participation (2011-2012) on the Expert Advisory Committee of the President’s Council of Advisors on Science and Technology (PCAST) for a special report commissioned by President Obama on “Propelling Innovation in Drug Discovery, Development, and Evaluation.” The project also helped to lay the intellectual foundation for the Adaptive Pathways pilot program launched by the European Medicines Agency (EMA) in March 2014. Under Dr. Hirsch’s leadership, NEWDIGS continues to channel multi-stakeholder thought leadership to advance other critical enablers of ABI such as the engineering of new “precision” financing models for curative therapies in the US; the design/piloting of a next generation pharmaceutical innovation ”learning ecosystem” for a target disease in Massachusetts; and interactive simulation methods/tools for collaborative system innovation. Dr. Hirsch has held a number of leadership roles that leverage her broad clinical background (Internal Medicine, Emergency Medicine, and Psychiatry) along with her passion for addressing the innovation gap between science and the system. Prior to joining MIT, she worked in commercial strategy at Millennium Pharmaceuticals, and was founder and CEO of a boutique entrepreneurial venture, funded by Boston’s Beth Israel Hospital. She has held faculty appointments at the medical schools of Harvard, Brown, and Tufts.
Omar Ishrak, PhD
Chairman & CEO, Medtronic
Omar Ishrak has served as Chairman and Chief Executive Officer of Medtronic since June 2011. Medtronic is the world’s leading medical technology company, with $29 billion in annual revenue, and operations reaching more than 160 countries worldwide. Medtronic offers technologies and solutions to treat a wide range of medical conditions, including cardiac and vascular diseases, respiratory, neurological and spinal conditions, diabetes, and more. The Medtronic Mission is to alleviate pain, restore health, and extend life for millions of people around the world. Since joining Medtronic, Omar has focused the company on three core strategies of Therapy Innovation, Economic Value and Globalization. These three strategies form the basis for Medtronic’s efforts to partner with its customers to drive high quality patient outcomes, expand patient access to healthcare, and lower costs in health care systems around the world. In 2014, Omar engineered the acquisition of Covidien, a $10 billion global manufacturer of surgical products and supplies. The acquisition of Covidien was the largest medical technology acquisition in the history of the industry. Omar joined Medtronic from General Electric Company, where he spent 16 years, most recently as President and CEO of GE Healthcare Systems, a $12 billion division of GE Healthcare, with a broad portfolio of diagnostic, imaging, patient monitoring and life support systems. Omar also served as an Officer and a Senior Vice President of GE. Earlier in his career, Omar amassed 13 years of technology development and business management experience, holding leadership positions at Diasonics/Vingmed, and various product development and engineering positions at Philips Ultrasound. He grew up in Bangladesh, and earned a Bachelor of Science degree and Ph.D. in Electrical Engineering from the University of London, King's College. He is also a Fellow of King’s College. Omar currently serves as co-chair of the World Economic Forum’s Health and Healthcare Community, which includes global leaders focused on shaping the future of health and healthcare. Key areas of focus for this community include promoting healthy behaviors, better management of future pandemics/epidemics, increasing global access to care, and increasing value in healthcare systems to advance healthcare delivery and improve patient outcomes. Omar is a member of the Board of Directors of Intel, a global technology company with more than $59 billion in annual revenue. Omar is a member of the Board of Trustees of the Asia Society, the leading educational organization dedicated to promoting mutual understanding and strengthening partnerships among peoples, leaders and institutions of Asia and the United States in a global context. He is also a member of the Minnesota Public Radio Board of Trustees.
Joseph Jimenez
Former CEO, Novartis

From 2010 to 2018, Joseph Jimenez held the position of Chief Executive Officer (CEO) of Novartis, one of the world’s leading pharmaceutical companies. Under his leadership, Novartis developed one of the largest pipelines of self-originated drugs in the industry, driven by a strong commitment to R&D. Mr. Jimenez also transformed the company’s portfolio to focus on innovative patented medicines under Novartis Pharmaceuticals and Novartis Oncology, generics under Sandoz, and eye care devices under Alcon.

Prior to serving as CEO of Novartis, Mr. Jimenez held the position of Division Head, Novartis Pharmaceuticals. He joined Novartis in 2007 as Division Head, Novartis Consumer Health. Before that, Mr. Jimenez served as president and CEO of the North American and European businesses for the H.J. Heinz Company.

Mr. Jimenez is currently a member of the Board of Directors of General Motors Company. Additionally, he served on the Board of Directors of Colgate-Palmolive Company from 2009 to 2015, and of AstraZeneca PLC, from 2002 to 2007.

He graduated in 1982 with a bachelor’s degree from Stanford University and in 1984 with a Master of Business Administration from the University of California, Berkeley, both in the United States.

Jeffrey B. Kindler
CEO, Centrexion Corporation

Jeff Kindler is a healthcare executive, investor and advisor who has held leadership positions at some of the world's most recognized companies. With more than three decades of experience, Kindler is a leading expert in pharmaceuticals and other health care sectors; corporate legal matters including regulation, litigation, compliance and crisis management; brand and franchise management; board and corporate governance; and executive leadership.

Currently, Kindler serves as CEO of Centrexion Corporation, a privately held biotherapeutics company developing pain therapies; Executive Chairman of vTv, a pharmaceutical development company; Venture Partner at Lux Capital, a leading venture capital firm; Managing Director at Starboard Capital Partners, a private equity firm; and a principal in and advisor to a number of privately held health care firms and sponsors. He is also Global Chair of the GLG Institute, a membership-based learning community for leading executives, and serves as a member of President Obama's Management Advisory Board.

Kindler serves on the boards of a number of publicly and privately held health care companies as well as several not-for-profit institutions including Tufts University.

Kindler was formerly the Chairman and Chief Executive Officer of Pfizer, the world's largest research-based biopharmaceutical company, which he joined in January 2002. As CEO, Kindler led Pfizer’s $68 billion merger and acquisition of Wyeth, diversified Pfizer’s product portfolio, improved its R&D pipeline, and reshaped the company’s commercial, innovation, and leadership models to drive growth and cultural change. He joined Pfizer as Executive Vice President and General Counsel and, prior to his appointment as CEO in July 2006, he served as a Vice Chairman of the company, responsible for Pfizer’s corporate affairs including worldwide legal, regulatory and patent matters as well as a range of public affairs and communications functions, and serving as a member of the four-person executive committee overseeing global business operations.

While at Pfizer, Kindler worked with former President Bill Clinton to help bring medicines to impoverished patients in the developing world through public-private pharmaceutical partnerships. He also represented the pharmaceutical industry in U.S. government healthcare reform efforts, helping to increase access to affordable medicines while preserving an environment in which pharmaceutical firms can discover and develop innovative treatments.

In 1996, Kindler joined McDonald's Corporation as Executive Vice President and General Counsel, responsible for both legal and corporate affairs, and then moved into line management as President of Partner Brands, which included overseeing franchise, operations and marketing efforts for restaurant brands such as Boston Market, Chipotle Mexican Grill, Donato’s Pizza, and Pret a Manger. Before joining McDonald’s Corporation, Kindler was Vice President of Litigation and Legal Policy of the General Electric Company.

Prior to GE, Kindler practiced civil and criminal litigation as a partner at the Washington D.C. firm of Williams & Connolly. He began his career as an attorney at the Federal Communications Commission and served as a law clerk to Judge David L. Bazelon of the U.S. Court of Appeals of the D.C. Circuit and later as law clerk to U.S. Supreme Court Justice William J. Brennan, Jr.

Kindler earned his BA in 1977 from Tufts University summa cum laude and his JD in 1980 from Harvard magna cum laude, where he was an editor of the Harvard Law Review.

Joe Lonsdale
Partner, 8VC;
Founder, Palantir and Addepar

Joe Lonsdale is a partner at 8VC, a San Francisco-based venture capital fund. He was an early institutional investor in many notable companies including Wish, Oculus, Illumio, Virgin Hyperloop One, Blend, RelateIQ, ZenReach, Color Genomics and uBiome, and in 2016 and 2017 was the youngest member of the Forbes 100 Midas List.

Joe is a co-founder of Palantir, a multi-billion dollar global software company best known for its work in defense and finance. Most recently, he was a founding partner at Formation 8, the precursor fund to 8VC, which manages over 1.5 billion USD and is one of the top performing private funds. Before that, he founded Addepar, a leading wealth management technology platform, and OpenGov. He is also a founder of Affinity and Anduin. Previously, Joe was an early executive at Clarium Capital, which he helped grow into a large global macro hedge fund. He also worked with PayPal while he was at Stanford.

Joe received a B.S. in Computer Science from Stanford in 2003. He often lectures and writes on entrepreneurship, technology, and public policy.

Andrew Maas, PhD
Co-Founder & Co-Chief Scientist at Roam Analytics
Andrew graduated with a PhD in Computer Science from Stanford University in 2015, advised by Andrew Ng and Dan Jurafsky. His research focuses on large scale deep learning to solve some of the most challenging problems in data analytics and forecasting, speech recognition, natural language processing, and computer vision. Andrew has consulted for Coursera, where he built biometric classifiers; for other clients he has developed recommendation systems for TV content and unsupervised similarity discovery algorithms for legal patents. Andrew received his B.S. from Carnegie Mellon in 2009. In 2017, he was voted by Forbes as a top 30 UNDER 30 in Enterprise Technology.
Paul Markovich
President and CEO,
Blue Shield of California

Paul Markovich is president and CEO of Blue Shield of California, a 4-million-member nonprofit health plan with more than $17 billion in annual revenue that serves the state’s commercial, individual and government markets. Markovich assumed the position on January 1, 2013.

As president and CEO, Markovich drives Blue Shield's mission to ensure Californians' access to high-quality health care at an affordable price. In 2015, he led Blue Shield’s acquisition of Care1st Health Plan, marking the company’s entry into the Medi-Cal program.

A 20-year Blue Shield veteran, Markovich previously served as COO, in which capacity he oversaw Health Care Services, Network Management, e-Business, Marketing, Product Development, Customer Operations and Blue Shield's three business units offering medical and specialty benefits coverage.

Prior to his position as COO, Markovich served as senior vice president of the Large Group Business Unit and led the CalPERS business unit, significantly boosting membership and revenues in both roles.

This is Markovich's second stint with Blue Shield. Leading the company's Product Development unit in the late 1990s, Markovich introduced numerous products and services, including the first California HMO to allow self-referrals to specialists, and the Blue Shield website.

While away from Blue Shield, Markovich spent two-and-a-half years as an entrepreneur, co-founding a consumer-driven health plan. He then joined Definity Health, another consumer-driven plan based in Minneapolis, before returning to Blue Shield.

Markovich started his professional career as a management consultant with Booz Allen Hamilton in New York. He is a North Dakota native, a graduate of Colorado College (where he played Division I hockey), a Rhodes Scholar, husband and father. He serves on the board of directors of America’s Health Insurance Plans and California Association of Health Plans.

Governor Terry McAuliffe
72nd Governor of Virginia

In November 2013 Terry McAuliffe was elected the 72nd Governor of Virginia. As, Governor, McAuliffe has focused on equality for all Virginians, enhancing quality of life, and building a new diversified economy that makes economic opportunity a right, not a privilege.

To keep Virginia competitive, McAuliffe implemented major economic development initiatives designed to strengthen the Commonwealth’s pro-business climate, ensure efficient investment in world-class infrastructure and develop a 21st century workforce capable of meeting the needs of emerging businesses and industries.

As Governor, McAuliffe conducted a record 35 trade missions, to dozens of countries, personally delivering Virginia’s calling card to business leaders around the globe. As a result, hundreds of thousands of jobs were created and more than $20 billion in capital investment to communities across the Commonwealth, which is billions more than any previous governor. He oversaw the unemployment rate dropping from 5.4% to 3.6% and initial unemployment claims fall to a 44 year low. Personal income rose 12.3% during his term of office.

Protecting the rights of all Virginians was always a top priority for McAuliffe. He successfully vetoed a record 120 bills that would have taken Virginia backward. In doing so, McAuliffe protected women’s access to health care, Virginia’s world-class education system, the environment, the integrity of our electoral system and kept more guns off the streets.

He made unprecedented progress on the restoration of civil rights to rehabilitated felons who have completed their sentences and paid their debt to society. During his tenure, McAuliffe restored the rights of more than 173,000 Virginians, more than any other governor in U.S. history.

Under the McAuliffe Administration, the Department of Juvenile Justice reduced its population in state-operated Juvenile Correctional Centers by nearly two-thirds. Virginia has boasted the lowest adult recidivism rate in the nation for the past two straight years.

McAuliffe won bipartisan support for a historic $1 billion investment in public education and higher education, the most in Virginia history. As a result of his actions, students saw the lowest tuition increase in 15 years. He also successfully secured passage of a law establishing a pay-for-performance workforce training program, the first of its kind in the Nation. Virginia became the first state in the nation to adopt computer science and computational thinking standards in its K-12 curriculum.

Virginia became the first state to be designated as employer of National Service.

He led the effort to make Virginia the first state in America to be certified to have functionally ended veteran homelessness. In addition, 30,000 veterans were hired through the Virginia Values Veterans program, a six-fold increase.

McAuliffe won bipartisan support for legislation to reduce gun violence in Virginia. It was the first comprehensive gun legislation to become law in 24 years.

McAuliffe was twice elected chairman of the Chesapeake Bay executive council. He took executive action and Virginia became the first Southern State to implement a carbon reduction program.

He served as Chairman of the National Governors Association, where he used that leadership position to assist states as they strengthen their cyber security policies and infrastructure.

McAuliffe worked to build a solid cyber ecosystem in Virginia where he created a cyber security commission charged with developing industry relevant recommendations. He was the first governor to take executive action to secure consumer transactions and the Commonwealth’s data. Virginia now has most cyber companies.

President Obama appointed McAuliffe to NGA’s Council of Governors to provide advice on national security matters. McAuliffe is now working with Former Attorney General Eric Holder to combat Republican gerrymandering through the efforts of the National Democratic Redistricting Committee as the State Engagement Chair.

He currently serves as a Distinguished Visiting Professor at the Schar School of Policy and Government at George Mason University.

In politics and business, McAuliffe has worked with people from all walks of life and different political backgrounds. He entered National politics at the age of 23 as the national finance director for President Jimmy Carter. He was elected Democratic National Committee chairman In 2000 and served until 2005. He co-chaired President Bill Clinton's 1996 campaign for reelection and his 1997 Presidential Inauguration.He was also chairman of the 2000 Democratic National Convention and chairman of Hillary Clinton's 2008 Presidential Campaign.

McAuliffe and his wife Dorothy were married in 1988. They have five children.

The youngest child growing up in a middle class family, McAuliffe has been a lifelong entrepreneur. So, at age 14, he started a business paving driveways for neighbors and local businesses. Since then, he has worked with and led dozens of businesses in diverse sectors of the economy helping to improve companies and create economic opportunity.

Mark McClellan, MD
Director, Margolis Center for Health Policy at Duke University
Mark McClellan, MD, PhD, is the Robert J. Margolis Professor of Business, Medicine, and Policy, and Director of the Margolis Center for Health Policy at Duke University. He is a physician- economist who focuses on quality and value in health care including payment reform, real-world evidence and more effective drug and device innovation. He is former administrator of the Centers for Medicare & Medicaid Services and former commissioner of the U.S. Food and Drug Administration, where he developed and implemented major reforms in health policy. He was previously Senior Fellow at the Brookings Institution and a faculty member at Stanford University.
William F. McKeon
President and Chief Executive Officer, Texas Medical Center

William “Bill” McKeon is the President and Chief Executive Officer of the Texas Medical Center. He is responsible for driving strategic, operational and programmatic initiatives across the Texas Medical Center’s member institutions to enhance its leadership position in the life sciences. McKeon joined the Texas Medical Center in 2013 as executive vice president, chief operating officer and chief strategy officer.

McKeon attended Roger Williams University on the Harold G. Way Scholarship for Leadership and Academic Excellence. He worked throughout his college years as a legal intern at Asquith, Merolla, Anderson, Ryan & Wiley – a prestigious law firm in Providence, Rhode Island. He graduated with top honors with a Bachelor of Science in Legal Studies. He earned his master’s degree from University of San Francisco School of Management.

McKeon began his professional career at Du Pont de Nemours. He initially led the implementation of large news publishing systems around the world and was later promoted to run marketing and business development. During his time at Du Pont, McKeon lived throughout the United States, United Kingdom and Sweden. His career shifted to health care when he was recruited to Stanford University Medical Center, where he initially led the Cardiovascular Medicine and Cardiothoracic Surgery business. He was then promoted to Director of Market Development for all 17 business lines at Stanford. He then went to Raytel Medical Systems - the largest cardiac monitoring business in the United States. He served as Executive Director and digitized all businesses so that physicians could see patients’ EKGs online from anywhere in the world. At Raytel, he won the Computer World Smithsonian Award in Medicine.

McKeon came to Houston to join U.S. Oncology, which provides cancer care for over 25 percent of the U.S. population. There, he served as Senior Vice President of Marketing and Pharmaceutical Business Relations. During McKeon’s tenure, U.S. Oncology grew from $250 million to $1.4 billion, filed for IPO and was later acquired by the McKesson Corporation. McKeon then moved to Medtronic Inc., the largest medical device company in the world. He led Strategy and Emerging Technologies across all of the Medtronic businesses. His main focus was to define the digital strategy for all Medtronic medical devices so that they could connect to cellular devices.

McKeon was then recruited to serve as President and CEO of Microport Inc. in Shanghai. He grew the business from $17 million to $157 million in two years. Additionally, he diversified the business from one line to four lines and prepared the company for IPO. Today, Microport is listed on the Hong Kong stock exchange.

McKeon then moved to London to serve as President and CEO of Cellnovo, the first mobile diabetes management system in the world. He raised $10 million for its Series A round and $57 million for the Series B. Cellnovo is public on the European Exchange.

Lloyd Minor, MD
Dean, Stanford University School of Medicine
Lloyd B. Minor, MD, is a scientist, surgeon, and academic leader. He is the Carl and Elizabeth Naumann Dean of the Stanford University School of Medicine, a position he has held since December 2012. He is also a professor of Otolaryngology–Head and Neck Surgery and a professor of Bioengineering and of Neurobiology, by courtesy, at Stanford University. As dean, Dr. Minor plays an integral role in setting strategy for the clinical enterprise of Stanford Medicine, an academic medical center that includes the Stanford University School of Medicine, Stanford Health Care, and Stanford Children’s Health and Lucile Packard Children’s Hospital Stanford. With his leadership, Stanford Medicine has established a strategic vision to lead the biomedical revolution in Precision Health, a fundamental shift to more proactive and personalized health care that empowers people to lead healthy lives. Before coming to Stanford, Dr. Minor was provost and senior vice president for academic affairs of The Johns Hopkins University. Prior to his appointment as provost in 2009, Dr. Minor served as the Andelot Professor and director (chair) of the Department of Otolaryngology–Head and Neck Surgery in the Johns Hopkins University School of Medicine and otolaryngologist-in-chief of The Johns Hopkins Hospital. With more than 140 published articles and chapters, Dr. Minor is an expert in balance and inner ear disorders. In the medical community, Dr. Minor is perhaps best known for his discovery of superior canal dehiscence syndrome, a debilitating disorder characterized by sound- or pressure-induced dizziness. He subsequently developed a surgical procedure that corrects the problem and alleviates symptoms. In 2012, Dr. Minor was elected to the National Academy of Medicine.
Senator George Mitchell
Partner & Chairman Emeritus,
DLA Piper

Senator George Mitchell has had a long and distinguished career. He served for several years as Chairman of DLA Piper, now Chairman Emeritus. Before that he served as a federal judge; as Majority Leader of the United States Senate; as Chairman of peace negotiations in Northern Ireland which resulted in an agreement that ended an historic conflict; and most recently as U.S. Special Envoy to the Middle East. In 2008 Time Magazine described him as one of the 100 most influential people in the world. Senator Mitchell is the author of five books. His most recent books are a memoir entitled The Negotiator: Reflections on an American Life, published in May 2015 and A Path To Peace, published in November 2016.

Brendan Mullen
Executive Vice President, American College of Cardiology

Brendan Mullen leads the strategy, business development, innovation, international affairs, marketing, and communications teams at the American College of Cardiology. Operating at the intersection of the College’s clinical, scientific, and business interests, he is responsible for shaping the mission and commercial applications of the ACC’s intellectual property and products in both domestic and international markets. Mr. Mullen also shares responsibility for the ACC’s innovation agenda and maintains special expertise in the National Cardiovascular Data Registry, clinical big data, analytics, quality improvement, and clinical pathways. Prior to his current role, Mr. Mullen developed and directed a suite of scientific, quality improvement, and payment recognition programs centered on the nation’s largest ambulatory cardiovascular data registry. Established in 2007, the PINNACLE Registry assesses adherence to evidence-based guidelines for coronary artery disease, heart failure, hypertension, atrial fibrillation, and diabetes and now contains over 50 million clinical patient records submitted by nearly 10,000 clinicians. He most recently co-founded the Institute for Computational Health with the Yale Center for Outcomes Research, an initiative intended to accelerate the application of advanced mathematics and computer science to medical research and decision-making. In addition to advising numerous healthcare start-ups on the clinical and commercial context of cardiovascular care, he maintains a personal interest in applied philosophy, particularly as it relates to the social, economic, and moral implications of the information revolution. He lives in Alexandria, VA with his wife and two young children.

Peter Orszag, PhD
Vice Chairman of Investment Banking & Global Co-Head of Healthcare, Lazard Freres & Co. LLC
Peter Orszag joined Lazard as a Managing Director and Vice Chairman of Investment Banking in May 2016. He is based in New York. Prior to joining Lazard, Mr. Orszag was with Citigroup (since 2011), where he was Vice Chairman of Corporate and Investment Banking at Citigroup, and Chairman of Citi’s Financial Strategy and Solutions Group. He is also a nonresident Senior Fellow in Economic Studies at the Brookings Institution. Mr. Orszag previously served as a Distinguished Visiting Fellow at the Council on Foreign Relations (2010-2015). He was the Director of the Office of Management and Budget (2009-2010), serving in President Barack Obama’s cabinet, and Director of the Congressional Budget Office (CBO) (2007-2008). Before leading the CBO, Mr. Orszag served as Director of The Hamilton Project (generating innovative solutions to support broad-based economic growth) and the Retirement Security Project (promoting retirement security amongst moderate- and lower-income families). Princeton University, B.A., summa cum laude in Economics; London School of Economics, Ph.D., Economics (Marshall Scholar)
DJ Patil, PhD
Former U.S. Chief Data Scientist
DJ Patil has held a variety of roles in Academia, Industry, and Government. Most recently he was appointed by President Obama to be the first U.S. Chief Data Scientist where his efforts led to the establishment of nearly 40 Chief Data Officer roles across the Federal government. He also established new health care programs including the Precision Medicine Initiative and the Cancer Moonshot, new criminal justice reforms including the Data-Driven Justice and Police Data Initiatives that cover more than 94 million Americans, as well as leading the national data efforts. He also has been active in national security and for his efforts was awarded by Secretary Carter the Department of Defense Medal for Distinguished Public Service which the highest honor the department bestows on a civilian. In industry, he led the product teams at RelateIQ which was acquired by Salesforce, was founding board member for Crisis Text Line which works to use new technologies to provide on demand mental and crisis support, and was a member of the venture firm Greylock Partners. He has also was Chief Scientist, Chief Security Officer and Head of Analytics and Data Product Teams at the LinkedIn Corporation where he co-coined the term Data Scientist. He has also held a number of roles at Skype, PayPal, and eBay. As a member of the faculty at the University of Maryland, his research focused on nonlinear dynamics and chaos theory and he helped start a major research initiative on numerical weather prediction. As an AAAS Science & Technology Policy Fellow for the Department of Defense, Dr. Patil directed new efforts to leverage social network analysis and the melding of computational and social sciences to anticipate emerging threats to the US. He has also co-chaired a major review of US efforts to prevent bioweapons proliferation in Central Asia and co-founded the Iraqi Virtual Science Library (IVSL). In 2104 he was selected by the World Economic Forum as a Young Global Leader and is also a Member of the Council of Foreign Relations.
Pamela Peele, PhD
Chief Analytics Officer UPMC Health Plan and UPMC Enterprises
Pamela Peele, Ph.D., is the Chief Analytics Officer at UPMC Insurance Services Division and UPMC Enterprises. Dr. Peele brings 13 years of direct patient care experience along with 12 years of academic research experience to her position as a leader of health care analytics at UPMC. She is responsible for creating innovative analytics that drive financial and clinical performance including economic modeling, predictive modeling, statistical analysis and machine learning. Prior to joining the UPMC in 2006, Dr. Peele was the Vice Chair of the Department of Health Policy & Management at the University of Pittsburgh Graduate School of Public Health. She currently holds faculty appointments in the Graduate School of Public Health and the School of Medicine at the University of Pittsburgh. She is core faculty at the Center for Research on Health Care at the University of Pittsburgh Medical Center and an elected fellow of the Centre for Interuniversity Research and Analysis on Organizations in Montreal, Canada. She has numerous published articles and book chapters. She was the first person chosen by IBM as an IBM Big Data Hero and was voted the 2014 IT News Men & Women of the Year as a top innovator in health care analytics. Dr. Peele has a BA in economics from Roanoke College in Salem, VA, and a MA and a PhD in economics from Virginia Tech in Blacksburg, VA.
Ambassador Tom Pickering
Vice Chairman, Hills & Company

Ambassador Pickering is Vice Chairman of Hills & Company, an international consulting firm providing advice to U.S. businesses on investment, trade, and risk assessment issues abroad, particularly in emerging market economies. He retired in 2006 as senior vice president international relations for Boeing. He has had a career spanning five decades as a U.S. diplomat, serving as under secretary of state for political affairs, ambassador to the United Nations, ambassador to Russia, India, Israel, Nigeria, Jordan and El Salvador. He also served on assignments in Zanzibar and Dar es Salaam, Tanzania. He holds the personal rank of Career Ambassador, the highest in the U.S. Foreign Service. He has held numerous other positions at the State Department, including executive secretary and special assistant to Secretaries Rogers and Kissinger and assistant secretary for the bureau of oceans, environmental and scientific affairs. He is based in Washington, DC.

Chris Potts, PhD
Professor, Stanford University Department of Linguistics
Chris Potts is Professor of Linguistics and, by courtesy, of Computer Science at Stanford, and Director of the Center for the Study of Language and Information (CSLI) at Stanford. In his research, he develops computational models of linguistic reasoning, emotional expression, and dialogue. He is the author of the 2005 book The Logic of Conventional Implicatures as well as numerous scholarly papers in linguistics and natural language processing.
Ambassador Susan E. Rice
Distinguished Visiting Research Fellow at the School of International Service, American University; Non-Resident Senior Fellow at the Belfer Center for Science and International Affairs at Harvard’s Kennedy School of Government

Ambassador Susan E. Rice is currently Distinguished Visiting Research Fellow at the School of International Service, American University, and a Non-Resident Senior Fellow at the Belfer Center for Science and International Affairs at Harvard’s Kennedy School of Government.

Previously, Ambassador Rice served President Barack Obama as National Security Advisor and U.S. Permanent Representative to the United Nations. In her role as National Security Advisor from July 1, 2013, to January 20, 2017, Ambassador Rice led the National Security Council Staff of approximately 400 defense, diplomatic, intelligence and development experts. She chaired the Cabinet-level National Security Principals Committee, provided the President daily national security briefings, and was responsible for coordinating the formulation and implementation of all aspects of the Administration's foreign and national security policy, including all diplomatic, intelligence, homeland security and military efforts.

As U.S. Permanent Representative to the United Nations and a member of President Obama's Cabinet (2009-2013), Rice worked to advance U.S. interests, defend universal values, strengthen the world's security and prosperity, and promote respect for human rights. In a world of 21st Century threats that pay no heed to borders, Ambassador Rice helped rebuild an effective basis for international cooperation that strengthened the United States’ ability to achieve its foreign policy objectives and made the American people safer. As US Ambassador to the UN, she marshalled and oversaw all U.S. contributions to the UN, which account for 22% of its regular budget and 28% of its peacekeeping budget, and championed the UN management and reform agenda.

From 2002-2008, Rice was a Senior Fellow at the Brookings Institution, where she conducted research and published widely on U.S. foreign policy, transnational security threats, weak states, global poverty and development.

Ambassador Rice served as U.S. Assistant Secretary of State for African Affairs from 1997-2001. In that role, she formulated and implemented U.S. policy towards 48 countries in Sub-Saharan Africa and oversaw the bureau’s annual operating budget of $100 million and almost $800 million assistance budget. She was responsible for the management of 43 U.S. Embassies and more than 5,000 U.S. and Foreign Service national employees. Rice was co-recipient of the White House's 2000 Samuel Nelson Drew Memorial Award for distinguished contributions to the formation of peaceful, cooperative relationships between states. From 1993-1997, she served as Special Assistant to the President and Senior Director for African Affairs at the National Security Council at the White House, as well as Director for International Organizations and Peacekeeping on the National Security Council staff.

Rice began her career as a management consultant with McKinsey and Company where she served natural resource, industrial and some consumer companies.

Ambassador Rice has previously served on numerous boards, including as an outside Director of the Bureau of National Affairs (now Bloomberg BNA), as well as Common Sense Media, the Beauvoir School in Washington DC, and the U.S. Fund for UNICEF. She is currently on the board of the Kennedy Center for the Performing Arts and a member of the Council on Foreign Relations.

Rice received her Master's degree (M.Phil.) and Ph.D (D.Phil.) in International Relations from New College, Oxford University, England, where she was a Rhodes Scholar. She was awarded the Chatham House-British International Studies Association Prize for the most distinguished doctoral dissertation in the United Kingdom in the field of International Relations in 1990. Ambassador Rice received her B.A. in History with honors from Stanford University in 1986, where she was junior Phi Beta Kappa and a Truman Scholar. In 2017, French President Francois Hollande presented Ambassador Rice with the Award of Commander, the Legion of Honor of France, for her contributions to Franco-American relations.

A native of Washington DC, Ambassador Rice is married to Ian Cameron, and they have two children. She is a sports enthusiast, avid tennis player, and retired basketball player.

Peter M. Robinson
Murdoch Research Fellow,
Hoover Institution

Peter M. Robinson is the Murdoch Research Fellow at the Hoover Institution, where he writes about business and politics, edits Hoover's quarterly journal, the Hoover Digest, and hosts Hoover's video series program, Uncommon Knowledge™.

Robinson is also the author of three books: How Ronald Reagan Changed My Life (Regan Books, 2003); It's My Party: A Republican's Messy Love Affair with the GOP, (Warner Books, 2000); and the best-selling business book Snapshots from Hell: The Making of an MBA (Warner Books, 1994; still available in paperback).

In 1979, he graduated summa cum laude from Dartmouth College, where he majored in English. He went on to study politics, philosophy, and economics at Oxford University, from which he graduated in 1982.

Robinson spent six years in the White House, serving from 1982 to 1983 as chief speechwriter to Vice President George Bush and from 1983 to 1988 as special assistant and speechwriter to President Ronald Reagan. He wrote the historic Berlin Wall address in which President Reagan called on General Secretary Mikhail Gorbachev to "tear down this wall!"

After the White House, Robinson attended the Stanford University Graduate School of Business. (The journal he kept formed the basis for Snapshots from Hell.) He graduated with an MBA in 1990.

Robinson then spent a year in New York City with Fox Television, reporting to the owner of the company, Rupert Murdoch. He spent a second year in Washington, D.C., with the Securities and Exchange Commission, where he served as the director of the Office of Public Affairs, Policy Evaluation, and Research. Robinson joined the Hoover Institution in 1993.

The author of numerous essays and interviews, Robinson has published in the New York Times, Red Herring, and Forbes ASAP, the Wall Street Journal, and National Review Online. He is the editor of Can Congress Be Fixed?: Five Essays on Congressional Reform (Hoover Institution Press, 1995).

In 2005, Robinson was elected to serve as a Trustee of Dartmouth College.

Robinson lives in northern California with his wife, their children and their dog, Crusoe.

His research papers are available at the Hoover Institution Archives.

Amir Rubin
President and CEO, One Medical

Amir Dan Rubin has sought to make significant positive impacts on health care throughout his career. He serves as President and CEO of One Medical, the leading membership-based, technology-enabled, national primary care organization focused on transforming health care.

Amir previously served as an EVP at UnitedHealth Group’s Optum division, where he served as a divisional CEO focused on helping to make the health system work better for everyone. Amir also previously served as President and CEO at Stanford Health Care—the academic health system affiliated with Stanford University—where he helped raise patient experience and quality scores to the highest levels in the nation, grow a regional network of care settings, and advance digital health and corporate partnerships in the heart of Silicon Valley. Amir also previously served as COO for UCLA Health System, COO for Stony Brook University Hospital, AVP at Memorial Hermann Health System, and management consultant with APM.

Amir holds MBA and MHSA degrees from the University of Michigan, and a BA from the University of California, Berkeley. He has also been awarded the EY Entrepreneur of the Year Award in Northern California for large companies.

John S. Rumsfeld, MD, PhD
Chief Innovation Officer for the American College of Cardiology (ACC) and Professor of Medicine at the University of Colorado School of Medicine
Dr. Rumsfeld is the Chief Innovation Officer for the American College of Cardiology (ACC) and Professor of Medicine at the University of Colorado School of Medicine. As Chief Innovation Officer, Dr. Rumsfeld is responsible for developing and implementing the innovation agenda for the ACC, investigating global and domestic market trends in the delivery of cardiovascular care and health information technology, and exploring new technologies and team--‐based approaches to health care. Previously, Dr. Rumsfeld served as National Director for Cardiology for the U.S. Veterans Health Administration (2012-2017), the largest integrated health system in the U.S. Dr. Rumsfeld was also Chief Science Officer and Chairman for the ACC's National Cardiovascular Data Registry (NCDR) programs from 2005-2016, and served on the ACC’s Board of Trustees from 2011-2017. Dr. Rumsfeld is past-Chair of the American Heart Association’s Quality of Care and Outcomes Research (QCOR) Scientific Council. A member of the American Society for Clinical Investigation (ASCI), Dr. Rumsfeld is an internationally recognized leader in cardiovascular quality of care and outcomes research, clinical registries, and healthcare analytics. In 2016, he received the Outstanding Lifetime Achievement Award for Quality of Care and Outcomes Research from the American Heart Association. He has >330 scientific publications and has presented at >120 conferences. Dr. Rumsfeld received his medical degree from the University of Chicago and doctoral degree in Epidemiology from the University of Colorado. He completed his internal medicine internship and residency at the University of California, San Francisco, and cardiology fellowship at the University of Colorado. Dr. Rumsfeld has been an attending cardiologist at the Denver VA Medical Center since 1999.
Mehran Sahami, PhD
Professor, Stanford Artificial Intelligence Laboratory
Mehran Sahami is a Professor (Teaching) and Associate Chair for Education in the Computer Science department at Stanford University. He is also the Robert and Ruth Halperin University Fellow in Undergraduate Education. Prior to joining the Stanford faculty in 2007, he was a Senior Research Scientist at Google for several years. His research interests include computer science education, machine learning, and web search. He has published numerous papers and has over 20 patent filings on a variety of topics including machine learning, data analytics, web search, recommendation engines in social networks, and email spam filtering that have been deployed in commercial applications.
Susan Schaeffer
Editor, BioCentury

As chief editor since 2012, Susan has developed BioCentury's coverage to advance new thinking in clinical development, regulation, pricing and market access to speed innovations to patients. Her work has been cited in regulatory filings and has influenced global biopharmaceutical companies to begin working on pricing experiments that can improve access to healthcare innovation.

She was previously senior editor in charge of Product Discovery & Development coverage from 2010 through 2012. She was managing editor of BioCentury and BioCentury Extra from 2004 through 2010. Susan joined BioCentury in 2003 after 10 years as an editor in the consumer packaged goods sector, including work with international strategy consultants Kurt Salmon Associates.

Dr. Kori Schake, PhD
Deputy Director-General of the International Institute for Strategic Studies
Dr. Kori Schake is the Deputy Director-General of the International Institute for Strategic Studies. She is the author of Safe Passage: the Transition from British to American Hegemony (Harvard, 2017) and editor with Jim Mattis of Warriors and Citizens: American Views of Our Military (Hoover Institution, 2016). She has worked for the National Security Council staff, the State Department’s Policy Planning Staff, and both the military and civilian staffs in the Pentagon. In 2008 she was senior policy advisor on the McCain presidential campaign. She taught Thinking About War at Stanford University, and also in the faculties of the United States Military Academy, the Johns Hopkins School of Advanced International Studies, and the University of Maryland.
Sara Singer, PhD
Professor of Medicine at the Stanford University School of Medicine and Professor by courtesy at the Stanford Graduate School of Business
Sara J. Singer, M.B.A., Ph.D., is a Professor of Medicine at the Stanford University School of Medicine and Professor by courtesy at the Stanford Graduate School of Business. She is affiliated faculty with the Freeman Spogli Institute for International Studies, Center for Health Policy/Center for Primary Care and Outcomes Research, Center for Innovation in Global Health, and Clinical Excellent Research Center. Her research in the field of health care management and policy focuses on how organizational leadership and culture impact efforts to implement health delivery innovations, integrate patient care, and improve safety and reliability of health care organizations. A key feature of this research is the development of survey instruments that measure provider and patient perspectives on key interpersonal and organizational factors, enabling benchmarking, rapid and reliable feedback about the effectiveness and comparative effectiveness of delivery system innovations, and broader dissemination of more successful interventions. Previously, Dr. Singer was Professor of Health Care Management and Policy at the Harvard T. H. Chan School of Public Health and the Department of Medicine at Harvard Medical School in the Mongan Institute for Health Policy, Massachusetts General Hospital. She acted as Director of Graduate Studies of the Harvard PhD in Health Policy Program (2016-2017) and Co-Chair of the Health Policy PhD Program’s Management Track (2013-2017), Director of the Healthcare Management Field of Study for the Masters in Public Health Program at the Harvard Chan School (2015-2017), Implementation Research Director for the Safe Surgery 2015 initiative (2010-2017), and Member of the University Benefits Committee (2012-2017). She was also Evaluation Co-Chair for Massachusetts’ Proactive Reduction in Outpatient Malpractice: Improving Safety Efficiency and Satisfaction (PROMISES) program (2010-2014) and Evaluation Team Member for the Academic Innovations Collaborative / Comprehensive, Accessible, Reliable, Exceptional and Safe (AIC / CARES) Collaborative (2012-2106). She also co-founded and served as Executive Director for the Center for Health Policy at Stanford, where she was a Senior Research Scholar and Lecturer (1993-2003). Dr. Singer served as Staff Director for the California Managed Care Improvement Task Force (1997-98), a Senior Legislative Assistant for Health Policy in the US House of Representative (1994), and Health Policy Analyst at the Office of Management and Budget (1992). Dr. Singer directs the AHRQ-funded Engineering High Reliability Learning Lab (2015-present). She has published more than 100 articles in academic journals and books on healthcare management, health policy, and health system reform. Her publications have won numerous awards, including best paper awards from the Academy of Management’s Health Care Division in three consecutive years 2009, 2010, and 2011. She is the recipient of the 2013 Avedis Donabedian Healthcare Quality Award from the American Public Health Association and the 2014 Teaching Citation Award from the Harvard School of Public Health. Dr. Singer has conducted numerous studies for the Agency for Healthcare Research and Quality, Veterans Administration Health Services Research & Development, and private foundations related to measuring and improving organizational culture, learning, teamwork, patient safety, integrated patient care, and the financing and delivery of health care. She holds an A.B. degree in English from Princeton University, a M.B.A. degree with a Certificate in Public Management from Stanford University, and a Ph.D. from Harvard University in Health Policy/Management with a concentration in organizational behavior. Her husband, Gordon Bloom, is founder of the Social Entrepreneurship Collaboratory (SE Lab) at Harvard, Princeton, and Stanford Universities. They live with their children, Audrey (18) and Jason (15) in Portola Valley, CA.
John Thornhill
Innovation Editor, The Financial Times

John was appointed the Innovation Editor on February 2016. Prior to that John has been the deputy editor at the Financial Times since September 2012. He was appointed Financial Times’ news editor, based in London on the main news desk, in January 2009. Prior to this he spent four years in Paris as the editor of the European edition of the Financial Times.

Joining the FT in 1988 as a graduate trainee, Thornhill has been the Paris bureau chief, world news editor, Asia editor, Moscow bureau chief and a Lex columnist.

John founded and runs the FT's 125 executive forum, which holds monthly meetings for senior executives from a range of industries. Previous speakers have included Bill Gates, Jack Dorsey, Ana Botin, and Mark Carney.

In his spare time, John is a keen cyclist and plays chess. He also takes his long-suffering son to support Sunderland football club.

Kismet Toksu
CEO, eBenefits

Kismet Toksu is president of eBenefits, a cloud-based software and services company that helps human resource professionals, brokers, and carriers meet their short- and long-term strategic goals by providing high-tech, high-touch benefits administration, private exchange, and ACA compliance solutions on a single platform. As the executive leader, Ms. Toksu has overall responsibility for eBenefits’ strategy, performance, and team.

Prior to joining eBenefits, Ms. Toksu was president of Candor Consulting and served BCBS Michigan as a market-leading innovator for six years. There she was a member of the Health Care Reform Strategy Core Team, leading strategy and execution. Ms. Toksu was credited with delivering the nation’s first private health care exchange supporting group active and retiree segments. In addition, she launched BCBS Michigan’s successful Consumer Directed Health (CDH) business.

While at Optum Health, a United Healthcare company, Ms. Toksu was a Senior Strategy Consultant leading new business launches, portfolio re-positioning, and optimized operations management for national and regional health plans, provider organizations, brokerage firms, and vendors.

As Vice President at Lumenos, a start-up venture sold to WellPoint, Ms. Toksu successfully led business development and strategic alliances. In addition, Ms. Toksu directly tested consumer choice products with mid-market employers, engaged and educated consumers, and was a key contributor to the launch of a private label platform for health plans.

Kismet Toksu was Senior Vice President-Strategic Marketing, Vice President/Group Publisher, and Director, contributing to the rapid success of Phillips International. She was recognized for significant revenue growth and profit contributions through product innovation and acquisition.

A graduate from the University of Texas and Six Sigma Black Belt, Ms. Toksu is a frequent speaker and white paper author and is a member of ASSET STEM Education’s Board of Director.

Alex Turkeltaub
CEO and Co-Founder, Roam Analytics

Alex is the Co-Founder and Chief Executive of Roam. Prior to Roam, Alex co-founded and was the Chief Executive of Frontier Strategy Group (FSG), a venture-backed data and analytics company focused on emerging markets, which currently serves over 250 leading multinationals. Alex and his family immigrated to the United States from the Soviet Union in 1988; he holds BA and MA degrees in International Relations from Stanford University and a JD from the Yale Law School.

2018 EDITION PROGRAM


View event schedule below.

Tuesday, May 8, 2018
David and Joan Traitel Building
Stanford University
6:00 PM
Arrival, Registration & Cocktail Hour
Venue: Stanford University – David and Joan Traitel Building

7:00 PM
Opening Remarks
Alex Turkeltaub, CEO and Co-Founder, Roam Analytics
Jeff George and Jeff Kindler, LIGHT Co-Chairs


Keynote conversation: A Chinese Century or American Revival: Geopolitics at a Crossroads
Moderator: Peter Robinson, Research Fellow, Hoover Institution
Governor Haley Barbour, Founding Partner, BGR Group
Senator George Mitchell, Partner & Chairman Emeritus, DLA Piper
Ambassador Thomas Pickering, Vice Chairman, Hills & Company
Ambassador Susan Rice, Distinguished Visiting Research Fellow at the School of International Service, American University; Non-Resident Senior Fellow at the Belfer Center for Science and International Affairs at Harvard’s Kennedy School of Government
Venue: Stanford University – David and Joan Traitel Building

Wednesday, May 9, 2018
Frances C. Arrillaga Alumni Center, Stanford University
8:00 AM – 9:00 AM
Networking Breakfast
Provided by Morgan Stanley & The LIGHT Conference
Venue: Stanford University – Frances C. Arrillaga Alumni Center

9:00 AM – 9:10 AM
Welcome Remarks
Chris Potts, PhD, Professor of Linguistics and, by courtesy, Computer Science, and Director, Center for the Study of Language and Information, Stanford University
Video Message from House Majority Leader Kevin McCarthy
Venue: Stanford University – The Frances C. Arrillaga Alumni Center

9:10 AM – 10:30 AM
Opening plenary: Become Technology Companies or Die -- Will Artificial Intelligence (AI) Define the Healthcare Industry of Tomorrow?
Moderator: Peter Orszag, Vice Chairman of Investment Banking and Managing Director and Global Co-Head of Healthcare, Lazard Freres & Co.
Peter Brabeck-Letmathe, Chairman Emeritus, Nestlé S.A.
Bill George, Senior Fellow, Harvard Business School; Former Chairman and CEO, Medtronic; Author of “Discover Your True North”
George Halvorson, Chair and CEO of the Institute for InterGroup Understanding
Omar Ishrak, CEO, Medtronic
DJ Patil, Former U.S. Chief Data Scientist
Venue: Stanford University – Frances C. Arrillaga Alumni Center

10:30 AM – 11:30 AM
The Changing Nature of Evidence in Healthcare -- Now Data is King
Moderator: Mark McClellan, MD, Director of the Robert J Margolis Center for Health Policy and the Margolis Professor of Business, Medicine and Health Policy at Duke University
Olivier Brandicourt, CEO, Sanofi
Prof. M. Kate Bundorf, Associate Professor of Health Research and Policy at the Stanford School of Medicine; Associate Professor at the Stanford Graduate School of Business
Joe Jimenez, Fmr CEO, Novartis
Andrew Maas, PhD, Co-Founder & Co-Chief Scientist, Roam Analytics
Venue: Stanford University – The Frances C. Arrillaga Alumni Center

11:30 AM – 12:00 PM
In Conversation: Healthcare & Technology Leaders
Moderator: John Thornhill, Innovation Editor, Financial Times
Joe Lonsdale, Founding Partner 8VC, Co-Founder, Palantir & Addepar
Paul Markovich, CEO, Blue Shield of California
Kismet Toksu, CEO, eBenefits
Venue: Stanford University – The Frances C. Arrillaga Alumni Center

12:00 PM – 1:00 PM
Networking Lunch
Venue: Stanford University – The Frances C. Arrillaga Alumni Center

1:00 PM – 1:50 PM
Plenary: The Cutting Edge of Innovation -- What's State of the Art, What Does it Mean for Healthcare
Moderator: Paul Cheesbrough, Chief Technology Officer, 21st Century Fox
Gigi Hirsch, MD, Executive Director, MIT Center for Biomedical Innovation
Chris Potts, PhD, Professor of Linguistics and, by courtesy, Computer Science, and Director, Center for the Study of Language and Information, Stanford University
Mehran Sahami, PhD, Professor and Associate Chair for Education in Computer Science, and the Robert and Ruth Halperin University Fellow in Undergraduate Education, Stanford University
Venue: Stanford University – The Frances C. Arrillaga Alumni Center

1:50 PM – 2:50 PM
Plenary: Government and Health Innovation: Standing in the Way or Driving Change?
Moderator: Dr. Kori Schake, PhD, Deputy Director-General of the International Institute for Strategic Studies (IISS)
Governor Haley Barbour, Founding Partner, BGR Group
John Cochrane, PhD, Jack and Rose-Marie Anderson Senior Fellow at the Hoover Institution
Ron Cohen, MD, President & CEO, Acorda Therapeutics
Governor Gray Davis, Of Counsel, Loeb & Loeb; Fmr Governor, California
James Greenwood, President & CEO, Biotechnology Innovation Organization (BIO)
Venue: Stanford University – The Frances C. Arrillaga Alumni Center

2:50 PM – 3:05 PM
Networking and Coffee Break
Venue: Stanford University – The Frances C. Arrillaga Alumni Center

3:05 PM – 3:35 PM
In Conversation: A Provider’s Perspective
Healthcare and technology leaders in 1:1 discussion
Moderator: John Thornhill, Innovation Editor, Financial Times
Pamela Peele, PhD, Chief Analytics Officer, UPMC
Venue: Stanford University – The Frances C. Arrillaga Alumni Center

3:35 PM – 4:35 PM
Plenary: Patient Pathways in Cardiology: An Example of the Future
Moderator: Susan Schaeffer, Editor, BioCentury
John Glasspool, Board Member, Dalcor
Andrew Maas, PhD, Co-Founder & Co-Chief Scientist, Roam Analytics
Brendan Mullen, EVP, American College of Cardiology
Amir Rubin, CEO, One Medical
John Rumsfeld, MD, PhD, CIO, ACC
Sara Singer, PhD, Professor of Medicine, Stanford University School of Medicine and Professor by courtesy at the Stanford Graduate School of Business and Freeman Spogli Institute for International Studies
Venue: Stanford University – The Frances C. Arrillaga Alumni Center

4:35 PM – 5:30 PM
Plenary: Rapid Change or Linear Evolution: Where Will We Be a Year from Now?
Moderator: Martin Dewhust, Senior Partner, Global Pharmaceutical and Medical Products Practice, McKinsey & Company
Jeff George, CEO, Performance Health
Jeff Kindler, CEO, Centrexion
William F. McKeon, CEO, Texas Medical Center
Lloyd Minor, MD, Dean, Stanford University Medical School
Alex Turkeltaub, CEO and Co-Founder, Roam
Venue: Stanford University – The Frances C. Arrillaga Alumni Center

NEWS / PRESS


    • $100

    • 95 Disrupting Healthcare: Next Generation AI: Alex Turkeltaub

    • News — May 11, 2018

      CNBC Squawk Box: Disrupting Healthcare: Next Generation AI: Alex Turkeltaub Roam Analytics co-founder Alex Turkeltaub on how AI and big data is disrupting healthcare, and who these new applications are built to serve. .


      View
    • Register
    • $100

    • 96 LIGHT Forum: Healthcare of the Future Will be Shaped by Artificial Intelligence

    • News — May 10, 2018

      R&D Magazine: LIGHT Forum: Healthcare of the Future Will be Shaped by Artificial Intelligence A panel of industry stakeholders predicts that the healthcare industry is going to transform in the next five to ten years, largely because of growth in technologies like artificial intelligence (AI).


      View
    • Register
    • $100

    • 99 Trump White House panicked about China’s investment in AI: Alex Turkeltaub

    • News — May 8, 2018

      Trump White House panicked about China's investment in AI: Alex Turkeltaub Roam Analytics co-founder Alex Turkeltaub on efforts for U.S. to take the lead in the field of artificial intelligence.


      View
    • Register
    • $100

    • 100 Artificial Health care plays big role in race for AI dominance

    • News — May 8, 2018

      Artificial Health care plays big role in race for AI dominance The United States is not going to play second fiddle to China when it comes to artificial intelligence (AI). That’s why some of the smartest minds from companies including Facebook and Google have been invited to the White House on Thursday.


      View
    • Register
    • $100

    • 103 2018 LIGHT Forum Explores the Technology-Driven Healthcare Revolution

    • News — May 10, 2018

      Medical Design Technology: 2018 LIGHT Forum Explores the Technology-Driven Healthcare Revolution A panel of industry stakeholders predicts that the healthcare industry is going to transform in the next five to ten years, largely because of growth in technologies like artificial intelligence (AI).


      View
    • Register
    • $100

    • 104 2018 LIGHT Forum Explores the Technology-Driven Healthcare Revolution

    • Press Release — May 7, 2018

      2018 LIGHT Forum Explores the Technology-Driven Healthcare Revolution Leading voices in healthcare, technology and public policy convene to decide how technology will fundamentally transform the industry, impact patient care


      View
    • Register
    • $100

    • 105 UPMC Innovates: Lessons Learned from LIGHT Forum `17

    • News — May 22, 2017

      UPMC Innovates: Lessons Learned from LIGHT Forum `17

      UPMC HealthBeat - Representatives from UPMC earlier this month attended the inaugural Leaders in Global Healthcare and Technology (LIGHT) Forum at Stanford University’s campus in Palo Alto, California...


      View
    • Register
    • $100

    • 110 In-Depth: AI in Healthcare- Where we are now and what’s next

    • News — May 19, 2017

      In-Depth: AI in Healthcare- Where we are now and what's next

      MobiHealthNews - The problem we are trying to solve is one of productivity,” said Andy Slavitt, the former acting administrator of the Centers for Medicare and Medicaid Services said during the Light Forum.


      View
    • Register
    • $100

    • 115 The Inaugural LIGHT Forum Explored the Fundamental Transformation of Healthcare through the Power of Machine Learning and Artificial Intelligence

    • Press Release — May 18, 2017

      The Inaugural LIGHT Forum Explored the Fundamental Transformation of Healthcare through the Power of Machine Learning and Artificial Intelligence

      Healthcare Facilities Today - At the heart of the Forum was the healthcare industry’s shift from selling products to offering solutions — moving towards a system founded on value and outcomes...


      View
    • Register
    • $100

    • 120 Technology is the tool to spur a healthcare revolution

    • News — May 15, 2017

      Technology is the tool to spur a healthcare revolution

      Financial Times - How AI can be further applied to the sector was the subject of the LIGHT Forum at Stanford last week.The forum’s recurring themes were that new technologies could help people take more responsibility for their own health...


      View
    • Register
    • $100

    • 125 Bloomberg Interview – Alex Turkeltaub

    • Video — May 15, 2017

      Roam Analytics CEO Alex Turkeltaub Interviewed on Bloomberg

      Bloomberg - Alex Turkeltaub co-founder and CEO of ROAM Analytics talks about the rise of AI at the LIGHT Forum in Stanford, California.


      View
    • Register
    • $100

    • 140 Bloomberg Interview – Peter Orszag

    • Video — May 12, 2017

      Peter Orszag Says ‘Math Doesn’t Work’ on GOP Health Bill

      Bloomberg - Peter Orszag, former director of the Office of Management and Budget, discusses the prospects for the GOP health bill with Bloomberg's Mike McKee


      View
    • Register
    • $100

    • 145 Bloomberg Interview – Gray Davis

    • Video — May 12, 2017

      Gray Davis on GOP Health-Care Bill, California’s Economy

      Bloomberg - Former California Governor Gray Davis discusses the GOP health-care bill and California's economy.


      View
    • Register
    • $100

    • 150 How Trump could bring drug prices down

    • News — May 12, 2017

      How Trump could bring drug prices down

      Washington Post - Mulvaney explained at the LIGHT Forum at Stanford University that drugmakers receive a “tremendous giveaway” from Medicare's prescription drug benefit.


      View
    • Register
    • $100

    • 155 A Top Trump Official Just Flunked The Jimmy Kimmel Test

    • News — May 12, 2017

      A Top Trump Official Just Flunked The Jimmy Kimmel Test

      HuffPost - Mulvaney, made the comments during the LIGHT Forum in response to a question about the “Jimmy Kimmel Test.”


      View
    • Register
    • $100

    • 160 Press Release – May 12

    • Press Release — May 12, 2017

      The Inaugural LIGHT Forum Explored the Fundamental Transformation of Healthcare through the Power of Machine Learning and Artificial Intelligence

      Over 250 global health and technology leaders attended the first-ever LIGHT Forum, focused on the transformational impact of data, artificial intelligence (AI) and machine learning (ML) on the global healthcare system....


      View
    • Register
    • $100

    • 165 Bloomberg Interview – Sir Martin Sorrell

    • Video — May 11, 2017

      WPP CEO Sees Amazon as Search Threat to Google

      Bloomberg - Martin Sorrell, CEO at WPP PLC, discusses the changes tech is bringing about in the ad industry. He speaks with Bloomberg's Michael McKee from the LIGHT Summit at Stanford University


      View
    • Register
    • $100

    • 170 Bloomberg Interview – Joe Lonsdale

    • Video — May 11, 2017

      Joe Lonsdale Sees Tech and Health Care Intersecting

      Bloomberg - Joe Lonsdale, 8VC founding partner, discusses tech's impact on healthcare with Bloomberg's Mike McKee


      View
    • Register
    • $100

    • 175 Mulvaney Agrees With ‘Jimmy Kimmel Test’

    • News — May 11, 2017

      Mulvaney Agrees With ‘Jimmy Kimmel Test’

      Washington Examiner - Mulvaney was asked by a member of the audience at the Light Forum at Stanford University in Palo Alto, Calif., if he agreed.


      View
    • Register
    • $100

    • 180 Trump and Obama budget chiefs spar over Obamacare replacement

    • News — May 11, 2017

      Trump and Obama budget chiefs spar over Obamacare replacement

      Washington Examiner - Mulvaney, President Trump's budget chief, and Orszag, who held the role for a time under former President Barack Obama, sparred Thursday at the Light Forum.


      View
    • Register
    • $100

    • 185 WPP’s Sorrell: Amazon Search Threat To Google

    • News — May 11, 2017

      WPP's Sorrell: Amazon Search Threat To Google

      Mediapost - At the LIGHT Summit, Sorrell said the group discussed the rise of Amazon because the company "is certainly a threat to Google in search."


      View
    • Register
    • Press Release

    • 190 Press Release – May 04

    • Press Release — May 04, 2017

      LIGHT Forum Reveals Final Speaker Lineup

      The upcoming LIGHT Forum 2017 on 10-11 May, will convene more than 200 high-level executives, medical technologists, and policymakers in global health and technology, to explore the impact and implications of AI and machine learning on health outcomes and business models...


      View
    • Register

CONTACT


LIGHT Forum Registration Headquarters

(510) 923-7199
(888) 886-6803
LIGHTForum@tpgnc.com
Monday - Friday
8:30 am - 5:00 pm, Pacific Time